|
Reference |
Supplier |
Description |
Unit |
Price excl. taxes |
|
|
|
EPY0001508 |
European Pharmacopoeia |
Picrotin 40mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001509 |
European Pharmacopoeia |
Fentanyl for system suitability Controlled Substance 15mg |
|
Price on demand
|
|
|
|
EPY0001510 |
European Pharmacopoeia |
Lactulose for peak identification 1900mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001511 |
European Pharmacopoeia |
Glibenclamide for peak identification 30mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001513 |
European Pharmacopoeia |
Melphalan - Reference Spectrum 1uc |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001514 |
European Pharmacopoeia |
Megestrol acetate 120mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001515 |
European Pharmacopoeia |
Rivastigmine impurity D 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001516 |
European Pharmacopoeia |
Rivastigmine hydrogen tartrate 350mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001517 |
European Pharmacopoeia |
Haloperidol for system suitability 25mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001518 |
European Pharmacopoeia |
Haloperidol for peak identification 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001519 |
European Pharmacopoeia |
Pioglitazone for system suitability 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001520 |
European Pharmacopoeia |
Pioglitazone hydrochloride 120mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001521 |
European Pharmacopoeia |
Amoxicillin trihydrate for performance verification 5000mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001522 |
European Pharmacopoeia |
Anastrozole 100mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001523 |
European Pharmacopoeia |
Ursolic acid 25mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001524 |
European Pharmacopoeia |
Megestrol acetate for system suitability 50mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001525 |
European Pharmacopoeia |
Basic butylated methacrylate copolymer 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001527 |
European Pharmacopoeia |
Aescin for LC assay HRS 150mg |
|
148.24 CHF
161.14 €
|
|
|
|
EPY0001528 |
European Pharmacopoeia |
Picrotoxinin 40mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001529 |
European Pharmacopoeia |
Buflomedil for peak identification TBC |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001531 |
European Pharmacopoeia |
Anastrozole impurity E (2,2'-[5-(hydroxymethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)) 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001532 |
European Pharmacopoeia |
Norethisterone acetate for system suitability 2.6mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001533 |
European Pharmacopoeia |
Praziquantel for system suitability 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001534 |
European Pharmacopoeia |
Amisulpride for system suitability (1.0015 mg) 1.0015mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001535 |
European Pharmacopoeia |
Pemetrexed impurity mixture 0.002mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001536 |
European Pharmacopoeia |
Fludarabine for system suitability 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001537 |
European Pharmacopoeia |
Purified quillaia saponins 30mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001538 |
European Pharmacopoeia |
Pemetrexed for system suitability 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001539 |
European Pharmacopoeia |
Pemetrexed disodium heptahydrate 200mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001540 |
European Pharmacopoeia |
Risedronate impurity E 2-(pyridin-3-yl)ethane-1,1-diyl]bis(phosphonic acid) 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001541 |
European Pharmacopoeia |
Risedronate sodium 2.5-hydrate 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001542 |
European Pharmacopoeia |
Insulin glargine 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001543 |
European Pharmacopoeia |
Actaea racemosa for assay CRS TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001544 |
European Pharmacopoeia |
Insulin glargine for peak identification 3.2mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001545 |
European Pharmacopoeia |
Chlorhexidine for system suitability 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001546 |
European Pharmacopoeia |
Gonadorelin for NMR identification 6mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001547 |
European Pharmacopoeia |
Propylene glycol 150mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001548 |
European Pharmacopoeia |
Labetalol impurity A 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)-amino]ethyl]benzoic acid 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001549 |
European Pharmacopoeia |
Oxcarbazepine impurity mixture 0.008mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001550 |
European Pharmacopoeia |
Poly(vinyl alcohol) 100mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001551 |
European Pharmacopoeia |
Abacavir for system suitability 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001552 |
European Pharmacopoeia |
Abacavir for peak identification 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001553 |
European Pharmacopoeia |
Ciclesonide 150mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001554 |
European Pharmacopoeia |
Ciclesonide containing impurity A (2'S)-2'-cyclohexyl-11b-hydroxy-3,20-dioxo-16bH-[1,3]dioxolo[4',5':16,17]pregna-1,4-diene-21-yl 2-methylpropanoate (S-epimer of ciclesonide) 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001555 |
European Pharmacopoeia |
Ciclesonide impurity B (2'R)-2'-cyclohexyl-11b,21-dihydroxy-16bH-[1,3]dioxolo[4',5':16,17]pregna-1,4-diene-3,20-dione 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001556 |
European Pharmacopoeia |
Ciclesonide impurity C 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001557 |
European Pharmacopoeia |
Poly (vinyl acetate) 100mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001558 |
European Pharmacopoeia |
Risedronate impurity A 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001559 |
European Pharmacopoeia |
Salvianolic acid B 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001560 |
European Pharmacopoeia |
Tanshinone IIa TBC |
|
152.32 CHF
165.57 €
|
|
